AMINOSYN II 3.5% M
AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
Approval overview AMINOSYN II 3.5% M is listed in Drugs@FDA under application 019437 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE Form and strength INJECTABLE;INJECTION - 3.5%;30MG/100ML;97MG/100ML;120MG/100ML;49MG/100ML Sponsor ICU MEDICAL INC Submission history Latest submission status date: 2016-06-06 00:00:00.
Structured Monograph
Clinical summary
Approval overview AMINOSYN II 3.5% M is listed in Drugs@FDA under application 019437 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AMINO ACIDS; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE Form and strength INJECTABLE;INJECTION - 3.5%;30MG/100ML;97MG/100ML;120MG/100ML;49MG/100ML Sponsor ICU MEDICAL INC Submission history Latest submission status date: 2016-06-06 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.